Market Research Logo

US Market Report for Hemostasis Devices 2017 - MedCore

EXECUTIVE SUMMARY
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
1.1 KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS
2.2.1 Gastro-Esophageal Reflux Disease (GERD)
2.2.2 Barrett's Esophagus
2.2.3 Digestive Cancer
2.2.4 Gastrointestinal bleeding
2.2.5 Bile Duct Disorders
2.2.6 Crohn’s disease
2.2.7 Ulcer
2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction
2.3 PATIENT DEMOGRAPHICS
2.3.11 Patient Demographics
2.3.11.1 All Digestive Diseases
2.3.11.2 Abdominal Wall Hernia
2.3.11.3 Chronic Constipation
2.3.11.4 Diverticular Disease
2.3.11.5 Prescriptions
2.3.11.6 Gastroesophageal Reflux Disease
2.3.11.7 Gastrointestinal Infections
2.3.11.8 Hemorrhoids
2.3.11.9 Inflammatory Bowel Disease
2.3.11.10 Liver Disease
2.3.11.11 Pancreatitis
2.3.11.12 Peptic Ulcer Diseases
2.3.12 Digestive Cancer
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Hemostasis Devices
3.1.1.1 Introduction
3.1.1.1.1 Product Matrix for Hemostasis Devices
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Hemostasis devices
3.3 CLINICAL TRIALS
3.3.1 Hemostasis devices
3.4 PRODUCT PIPELINES
3.4.1 Boston Scientific
3.4.1.1 AXIOS™ Stent and Electrocautery Enhanced Delivery System
3.4.1.2 Acquire™ Endoscopic Ultrasound Fine Needle Biopsy (FNB) Device
3.4.1.3 Safe Enteral Feeding Product
3.4.1.4 Rotatable Snare
3.4.2 Cook Inc.
3.4.2.1 Lehman Manometry Catheter
3.4.3 Olympus
3.4.3.1 Olympus EZ Shot 3 Plus - a single-use aspiration needle
3.4.3.2 Olympus ESG-200 Electrosurgical Generator
3.4.3.3 Retooled GI Benchmarking Service
3.4.3.4 Big Screen Surgery In 4K: VISERA 4K UHD System
3.4.3.5 TJF-Q180V Duodenoscope
3.4.3.6 From AR 2015 – new strategy plan for General Surgery Unit
3.4.4 Medtronic / Covidien
3.4.4.1 Safe Enteral Feeding Product line 2016
3.4.4.2 Barrx 360 Express RFA balloon catheter for Barrett's Esophagus
3.4.5 Avantis Medical Systems
3.4.5.1 Third Eye Panoramic Colonoscopy Device
3.4.6 Pentax Medical/ HOYA
3.4.6.1 H OPTIVISTA-EPK-i7010 Video Processor for endoscopy
3.4.7 Fujifilm
3.4.7.1 Sonart SU-1 Endoscopic Ultrasonic Processors
3.4.7.2 Double Balloon Endoscope (EN-580T)
3.4.8 US Endoscopy
3.4.8.1 Moray® micro forceps
3.4.9 CONMED Corporation
3.4.9.1 ABC D-Flex Probes
3.4.10 EndoChoice
3.4.10.1 FDA clearance for Orca™ Sterile, Single-Use Air/Water and Suction Valves
3.4.10.2 Third generation Fuse® Full Spectrum Endoscopy® System
3.4.10.3 RescueNet™ retrieval device
3.4.10.4 Lumos™ Adaptive Matrix Imaging System
3.4.11 Endogastric Solution
3.4.11.1 Next-generation version of EsophyX® Device - EsophyX® Z
3.4.12 Mederi Therapeutics
3.4.12.1 Stretta RFT3 Technology
3.4.13 C2 Therapeutics
3.4.13.1 Coldplay III Trial Validating the C2 CryoBalloon™ Focal Ablation System for treating Barret’s Esophagus
3.4.14 Medigus
3.4.14.1 Next generation MUSE™ System for the long-term treatment of GERD
3.4.15 Merit Medical Systems, Inc.
3.4.15.1 Corvocet Biopsy System
3.4.16 Medivators, Inc.
3.4.16.1 AmplifEYE™ endoscopic overtube
3.4.17 Fujifilm Medical Systems USA, Inc.
3.4.17.1 Fujifilm Diathermic Slitter (flushknife) and Fujifilm Diathermic Slitter (clutchcutter)
3.4.17.2 New additions for Double Balloon Endoscopy (DBE) platform and the Advanced Endoscopic Platform including FlushKnife and ClutchCutter
3.4.18 Cook Medical
3.4.18.1 New study “A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device (ASPRO)”
3.4.19 Vital Images, Inc.
3.4.19.1 Vitrea CT Colon Analysis
HEMOSTASIS DEVICE MARKET
4.1 MARKET OVERVIEW
4.2 MARKET ANALYSIS AND FORECAST
4.2.1 Total Hemostasis Device Market
4.2.2 Total Hemostasis Probe Market
4.2.2.1 Total Electrosurgical Probe Market
4.2.2.1.1 Conventional Electrosurgical Probe Market
4.2.2.1.2 Injection-Needle Probe Market
4.2.2.2 Heat Probe Market
4.2.2.3 Argon Plasma Coagulation Probe Market
4.2.3 Ligation Device Market
4.2.3.1 Ligation Band Market
4.2.3.2 Ligation Clip Market
4.2.4 Sclerotherapy Needle Market
4.2.5 Electrosurgical Generator Market
4.2.6.1 Electrosurgical Unit Market
4.2.7.1 Argon Module Market
4.3 DRIVERS AND LIMITERS
4.3.1 Market Drivers
4.3.2 Market Limiters
4.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Gastrointestinal Endoscopic Device Market Overview, U.S., 2016 & 2023
Chart 2 1: Male Incidence, Digestive Cancer, U.S., 2016
Chart 2 2: Male Deaths, Digestive Cancer, U.S., 2016
Chart 2 3: Female Incidence, Digestive Cancer, U.S., 2016
Chart 2 4: Female Deaths, Digestive Cancer, U.S., 2016
Chart 4 1: Hemostasis Device Market by Segment, U.S., 2013 – 2023
Chart 4 2: Hemostasis Device Market Breakdown, U.S., 2016
Chart 4 3: Hemostasis Device Market Breakdown, U.S., 2023
Chart 4 4: Total Hemostasis Device Market, U.S., 2013 – 2023
Chart 4 5: Total Hemostasis Probe Market, U.S., 2013 – 2023
Chart 4 6: Total Electrosurgical Probe Market, U.S., 2013 – 2023
Chart 4 7: Conventional Electrosurgical Probe Market, U.S., 2013 – 2023
Chart 4 8: Injection-Needle Probe Market, U.S., 2013 – 2023
Chart 4 9: Heat Probe Market, U.S., 2013 – 2023
Chart 4 10: Argon Plasma Coagulation Probe Market, U.S., 2013 – 2023
Chart 4 11: Total Ligation Device Market, U.S., 2013 – 2023
Chart 4 12: Ligation Band Market, U.S., 2013 – 2023
Chart 4 13: Ligation Clip Market, U.S., 2013 – 2023
Chart 4 14: Sclerotherapy Needle Market, U.S., 2013 – 2023
Chart 4 15: Electrosurgical Generator Market, U.S., 2013 – 2023
Chart 4 16: Leading Competitors, Hemostasis Device Market, U.S., 2016
List of Figures
Figure 1 1: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Gastrointestinal Endoscopic Device Market, U.S., 2012 – 2016
Figure 1 7: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016
Figure 1 8: Procedure Codes Investigated, U.S., 2016
Figure 1 9: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (1 of 4)
Figure 1 10: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (2 of 4)
Figure 1 11: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (3 of 4)
Figure 1 12: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (4 of 4)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 2 1: Leading Physician Diagnoses for GI Disorders, U.S., 2009
Figure 2 2: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (1 of 2)
Figure 2 3: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (2 of 2)
Figure 2 4: Digestive Cancer Statistics by Type and Gender, U.S., 2016
Figure 3 1: Core Companies, Hemostasis Device Market, U.S., 2016 (2 of 3)
Figure 3 2: Core Companies, Hemostasis Device Market, U.S., 2016 (2 of 3)
Figure 3 3: Core Companies, Hemostasis Device Market, U.S., 2016 (3 of 3)
Figure 3 4: Class 2 Device Olympus Electrosurgical Unit.
Figure 3 5: Hemostasis device– Effectiveness Study of the BioVac Direct Suction Device in Upper GI Bleeding
Figure 3 6: Hemostasis device– Argon Plasma Coagulation for Bleeding Peptic Ulcers
Figure 4 1: Hemostasis Device by Segment, U.S., 2013 – 2023 (US$M)
Figure 4 2: Total Hemostasis Device Market, U.S., 2013 – 2023
Figure 4 3: Total Hemostasis Probe Market, U.S., 2013 – 2023
Figure 4 4: Total Electrosurgical Probe Market, U.S., 2013 – 2023
Figure 4 5: Conventional Electrosurgical Probe Market, U.S., 2013 – 2023
Figure 4 6: Injection-Needle Probe Market, U.S., 2013 – 2023
Figure 4 7: Heat Probe Market, U.S., 2013 – 2023
Figure 4 8: Argon Plasma Coagulation Probe Market, U.S., 2013 – 2023
Figure 4 9: Total Ligation Device Market, U.S., 2013 – 2023
Figure 4 10: Ligation Band Market, U.S., 2013 – 2023
Figure 4 11: Ligation Clip Market, U.S., 2013 – 2023
Figure 4 12: Sclerotherapy Needle Market, U.S., 2013 – 2023
Figure 4 13: Electrosurgical Generator Market, U.S., 2013 – 2023
Figure 4 14: Electrosurgical Unit Market, U.S., 2013 – 2023
Figure 4 15: Argon Module Market, U.S., 2013 – 2023
Figure 4 16: Drivers and Limiters, Hemostasis Device Market, U.S., 2016
Figure 4 17: Leading Competitors, Hemostasis Device Market, U.S., 2016

US Market Report for Hemostasis Devices 2017 - MedCore

The value of the total U.S. market for hemostasis devices increased in 2016. Growth is expected to persist throughout the forecasted period and will be driven by increases in unit sales countered by a decrease in the ASP. The vast majority of units in this market are sold to hospitals, with only relatively few units used in the outpatient centers. The four segments have different growth profiles with ligation devices exhibiting low-single digit rate cannibalizing into other segment, and thus resulting in a negative trend within the hemostasis probe segment. The ESU segment remains relatively flat, as this is mainly the replacement market as of 2016. The needle segment is growing at 1% annually as physicians use it as part of the combination therapy. The major contributor to the unit growth in this market is ligation device segment due to high volume coupled with the low-single digit growth rate.

The U.S. market for hemostasis devices is defined in this report as hemostasis probes, ligation devices, sclerotherapy needles and electrosurgical generators. The largest segment in this market was ligation devices. This segment represented approximately 66.1% of the total market in 2016. The relatively large size of this segment is mainly due to these devices being used as both a stand-alone and combination therapy with other devices to address gastrointestinal (GI) bleeding. Also, several units of clips are often used during one procedure. The smallest segment in this market was electro surgical generators (ESUs) due to the longevity of this capital equipment that extends beyond ten years, only one unit required per room, and 100% penetration, all resulting in a lower annual sale volume. Most of the devices discussed in this chapter are single-use, except for reusable heat probes and capital equipment, electro surgical generators including argon modules.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;